Nordberg G
Acta Anaesthesiol Scand Suppl. 1984;79:1-38. doi: 10.1111/j.1399-6576.1984.tb02148.x.
Epidural (E.D.) and intrathecal (I.T.) morphine (M) analgesia were studied in patients with pain after thoracotomy. The role of the pharmacokinetic properties of M. for the associated analgesia was also evaluated. M. concentrations in CSF and plasma were assayed using gas chromatography with EC detection. Analgesia was evaluated as the time postoperative until the patients again required analgetics and were given meperidine intramuscularly (I.M.) for thoracic pain. A lumbar site of E.D. and I.T. injection of M. resulted in a variable but in general longlasting postoperative analgesia although delayed after I.T. administration. The mean duration of analgesia after E.D. administration was dose-related (8.6 +/- 2.0 h, 13.0 +/- 3.5 h, and 15.6 +/- 2.6 h; means +/- SEM for the 2, 4 and 6 mg groups, respectively), which was comparable to that achieved after I.T. administration of 0.25 to 0.50 mg M. M. concentrations in plasma after E.D. administration were comparable in variability and magnitude to those found after I.M. administration. The concentrations of M. in plasma were not related to the long duration of analgesia and may only contribute to analgesia shortly after the E.D. administration. The reported time course of analgesia after E.D. injection with a delayed onset corresponded with the appearance of M. in the CSF. Fifteen min after E.D. administration, M. was found in higher concentrations in CSF than in plasma, but peak levels were not seen until 2 h after the injection. Both the high content of M. in CSF as expressed by AUC, as well as peak concentrations in CSF, were related to the longlasting analgesia after E.D. administration. A protracted clearance of M. from the CSF as a cause of longlasting analgesia was not found, M. was eliminated with a similar half-life from CSF and plasma. The high CSF concentrations of M. seen after E.D. administration were the result of a direct uptake across the dura. In contrast, the appearance of M. in CSF after I.M. administration of 10 mg was slower. Maximal concentration of M. in the CSF was reached after 3 h and the peak levels were on average about 100 times less than those found after E.D. injection of 6 mg morphine. CSF and plasma reached pseudoeliquilibrium at a ratio around 0.9 after I.M. administration. This is to be compared with a CSF/plasma concentration ratio around 100 after E.D. administration. A comparison of M. concentrations in the CSF after thoracic and lumbar E.D. injection showed that spinal CSF rapidly yielded comparable concentrations at the lumbar level.(ABSTRACT TRUNCATED AT 400 WORDS)
对开胸术后疼痛患者进行了硬膜外(E.D.)和鞘内(I.T.)注射吗啡(M)镇痛的研究。同时评估了M的药代动力学特性对相关镇痛作用的影响。采用气相色谱-电子捕获检测法测定脑脊液(CSF)和血浆中的M浓度。镇痛效果通过术后至患者再次需要镇痛药并接受哌替啶肌内注射(I.M.)治疗胸痛的时间来评估。E.D.和I.T.注射M的腰椎部位可产生不同但总体持久的术后镇痛效果,不过I.T.给药后起效延迟。E.D.给药后镇痛的平均持续时间与剂量相关(2mg组为8.6±2.0小时,4mg组为13.0±3.5小时,6mg组为15.6±2.6小时;均值±标准误),这与鞘内注射0.25至0.50mg M后的效果相当。E.D.给药后血浆中M的浓度在变异性和幅度上与I.M.给药后相当。血浆中M的浓度与镇痛的持久时间无关,可能仅在E.D.给药后短时间内有助于镇痛。E.D.注射后报道的镇痛时间进程与CSF中M的出现相对应。E.D.给药后15分钟,CSF中M的浓度高于血浆,但直到注射后2小时才出现峰值水平。CSF中M的AUC以及峰值浓度均与E.D.给药后的持久镇痛有关。未发现M从CSF中清除延长是持久镇痛的原因,M从CSF和血浆中消除的半衰期相似。E.D.给药后CSF中M的高浓度是通过硬脊膜直接摄取的结果。相比之下,肌内注射10mg M后CSF中M的出现较慢。CSF中M的最大浓度在3小时后达到,峰值水平平均比E.D.注射6mg吗啡后低约100倍。肌内注射后CSF和血浆以约0.9的比例达到假平衡。相比之下,E.D.给药后CSF/血浆浓度比约为100。胸段和腰段E.D.注射后CSF中M浓度的比较表明,脊髓CSF在腰段迅速产生相当的浓度。(摘要截短至400字)